1.column:Serum short-chain fatty acid levels and their association with atopic dermatitis in pediatric patients
Zhenxiang WANG ; Lele CHEN ; Liping DONG ; Sheng WANG ; Jinlei XU ; Xinying CAI ; Fengli XIAO
Acta Universitatis Medicinalis Anhui 2026;61(4):763-769
ObjectiveTo investigate the metabolic alterations of serum short chain fatty acids (SCFAs) in pediatric patients with atopic dermatitis (AD) and their correlation with different clinical phenotypes using targeted metabolomics. MethodsThis study enrolled 87 AD patients and 67 healthy controls (HC). Serum levels of eight SCFAs were quantified by ultra-high-performance liquid chromatography-mass spectrometry. The associations between SCFAs and AD were assessed using various statistical methods. ResultsCompared with the HC group, levels of acetic acid (AA), propionic acid (PA), and caproic acid (CA) (P=0.002,P=0.002,P=0.043) decreased in the AD group. Logistic regression analysis identified AA (OR=0.449, 95% CI: 0.289–0.698) and PA (OR = 0.487, 95% CI: 0.324–0.732) as protective factors against AD. The combination of AA and PA yielded an area under the curve (AUC) greater than 0.7, indicating good diagnostic efficacy. Age-stratified analysis revealed that AA reduction was predominant in childhood, whereas PA reduction was predominant in adolescence. Pathway enrichment analysis showed significant enrichment of fatty acid biosynthesis (FDR=0.341, P=0.003) and vitamin K metabolism (FDR=1, P=0.039) pathways. Furthermore, subgroup analyses based on disease severity, personal/family history of atopy, and sex revealed no significant differences in SCFAs levels among the groups. ConclusionDifferential serum SCFAs and their enriched metabolic pathways may be implicated in the pathogenesis of AD.
2.Treatment Modalities and Long-Term Outcomes in Unruptured Vertebrobasilar Fusiform Aneurysms: A Nationwide Observational Cohort Study
Linggen DONG ; Dachao WEI ; Xiheng CHEN ; Mingtao LI ; Yang ZHAO ; Yong SUN ; Qingbin NIE ; Jun FENG ; Guomin XIAO ; Jinghua ZHOU ; Shengli HU ; Lifei FENG ; Lifeng QI ; Hongen LIU ; Geng GUO ; Yufang LI ; Renfu TIAN ; Jianghua YU ; Dianshi JIN ; Liang HAO ; Tian TIAN ; Shizhong ZHANG ; Yang WANG ; Liping LIU ; Ming LV
Journal of Stroke 2026;28(2):250-262
Background:
and Purpose Vertebrobasilar fusiform aneurysms (VBFAs) carry substantial morbidity and mortality, but optimal management for unruptured VBFAs remains unclear. We compared the safety and efficacy of conservative management (CM), stent-assisted coiling (SAC), and flow diverters (FDs) in patients with unruptured VBFAs, focusing on long-term prognosis.
Methods:
This study included data from a nationwide Chinese cohort of patients with vertebrobasilar dissecting aneurysms. Inverse probability of treatment weighting (IPTW) balanced confounders across groups. The primary outcome was poor prognosis (modified Rankin Scale score >2). Secondary outcomes included aneurysm rupture, ischemic stroke, compression symptoms, and VBFA-related deaths. Logistic regression estimated odds ratios (ORs) and 95% confidence intervals (CIs). Subgroup and sensitivity analyses were performed.
Results:
Among 1,115 patients with unruptured VBFAs, 838 (median age, 54 years; 655 men) were included. After IPTW, baseline characteristics were balanced. Median follow-up was 54 months. FD was associated with a lower risk of poor prognosis than CM (OR, 0.48 [95% CI, 0.30 to 0.77]; p=0.002), with no difference between CM and SAC. FD also reduced aneurysm rupture (OR, 0.20 [95% CI, 0.07 to 0.60]; p=0.004) and compression symptoms (OR, 0.30 [95% CI, 0.13 to 0.68]; p=0.004) versus CM. Time-to-event analyses further revealed significant differences in vertebral artery lesions and Type I–II VBFAs, whereas no significant differences were observed in basilar or vertebrobasilar junction lesions or in Type III–IV VBFAs.
Conclusions
Compared with CM, FD was associated with improved long-term outcomes in unruptured VBFAs, particularly in vertebral artery lesions and Type I–II VBFAs, although residual confounding cannot be excluded.
3.Construction and evaluation of a multi-base collaborative training system for anticoagulation specialty clinical pharmacists
Shujie DONG ; Liping DU ; Yatong ZHANG ; Zheng DING ; Wenxing PENG ; Zinan ZHAO ; Xiaoxiao LI ; Li YANG
China Pharmacy 2025;36(15):1837-1840
OBJECTIVE To enhance the training quality of anticoagulation specialty clinical pharmacists,address the resource limitations of a single training base,and promote homogenization of training quality.METHODS A multi-base joint training system for anticoagulation specialty clinical pharmacists in the Beijing area was established.A mixed research method was employed,collecting data through performance comparisons,questionnaires,and qualitative interviews to compare the differences between the joint training model(experimental group,n=16)and traditional teaching model(the control group,n=17).RESULTS The established joint training system encompassed a unified joint training teaching plan,the formation of a joint training teaching team,the establishment of joint theoretical teaching courses,the implementation of joint case discussions and literature presentations,as well as strengthening the assessment throughout the joint training process.Compared to the control group[theoretical assessment of(76.44±3.66)points,case assessment of(84.31±3.27)points],the experimental group students achieved higher scores in theoretical assessment[(79.85±4.64)points]and case assessment[(88.70±5.51)points](P<0.05).Through questionnaires and qualitative interviews,the trainees in experimental group were highly satisfied with the joint training model in terms of theoretical learning,communication skills,and teaching interaction.CONCLUSIONS The multi-base collaborative training system for anticoagulation specialty clinical pharmacists can integrate advantageous resources and significantly enhance the training effectiveness of anticoagulation specialty clinical pharmacists,offering value for wider promotion.
4.Study on the Mechanism of miR-381 Ameliorates Ischemic Stroke by Modulating the NF-κB Signaling Pathway
Youtao ZHANG ; Liping DONG ; Shutie LI
Journal of Medical Research 2025;54(8):94-100
Objective To explore the role and mechanism of miR-381 in the pathogenesis of ischemic stroke(IS).Methods A total of 90 patients with IS treated in the First Affiliated Hospital of Hebei North University between January 2020 and December 2022 were selected as the IS group,while 110healthy volunteers were selected as the control group.Real-time fluorescence quantitative polymerase chain reaction(RT-qPCR)was used to detect the difference of serum miR-381 between the two groups,and enzyme-linked immu-nosorbent assay(ELISA)was used to measure the differences of inflammatory markers interleukin-1β(IL-1β),interleukin-6(IL-6),and tumor necrosis factor-α(TNF-α)between the groups.The CCK-8 assay was used to evaluate the effect of miR-381 on the ac-tivity of human umbilical vein endothelial cell(HUVEC).Use TargetScan,Western blot and luciferase reporter assays to validate whether inhibitor of kappa B kinase(IKK)was a target gene regulated by miR-381.An in vitro model of oxygen-glucose deprivation(OGD)was constructed,and the effects of miR-381 over-expression or inhibition on apoptosis-and inflammation-related proteins were de-tected by RT-qPCR and Western blot.The diagnostic value of miR-381 for IS was evaluated using receiver operating characteristic curve(ROC).Results Compared with the control group,the serum miR-381 levels in the IS group were significantly down-regulated(P<0.05).In comparison to the mild IS group or small infarct volume group,serum miR-381 levels were significantly lower in patients with moderate to severe IS or large infarct volumes(P were<0.05,<0.01).Additionally,compared with the control group,the serum levels of IL-1 β,IL-6 and TNF-α in the IS group were significantly higher(P were<0.01,<0.05,<0.01).Furthermore,com-pared to the mild IS group or small infarct volume group,the serum levels of IL-1 β,IL-6,and TNF-α were significantly elevated in patients with moderate to severe IS group or large infarct volume group(P were<0.01,<0.05).CCK-8 results indicated that miR-381 promoted the viability of HUVEC.Dual-Luciferase reporter gene assay results demonstrated that IKK was a direct target of miR-381.Western blot results showed that over-expression of miR-381 inhibited the activation of p65 and inhibitor of NF-κB(IKB)pro-teins,promoted the expression of the anti-apoptotic protein B-cell lymphoma 2(Bcl-2),and suppressed the expression of the pro-apoptotic protein Bcl-2 associated X(BAX).RT-qPCR results showed that over-expression miR-381 reduced the levels of NF-κB mRNA and BAX mRNA,and increased the levels of Bcl-2mRNA.ELISA results indicated that over-expression miR-381 decreased the serum levels of TNF-α,IL-6 and IL-1 β(P were<0.05,<0.01,<0.01).ROC curve analysis showed that the sensitivity and specificity of miR-381 for diagnosing IS were 76.23%and 81.25%,respectively.Conclusion miR-381 can inhibit HUVEC apopto-sis and inflammatory responses by targeting IKK,indicating its potential as a therapeutic target for IS.
5.Expression and diagnostic value of serine-threonine kinase 1 and isochorismatase domain-containing 1 in gastric cancer
Jiangqiao ZHAO ; Liping FU ; Long YANG ; Zhiqiang DONG ; Shuli SONG ; Benxin YANG
The Journal of Practical Medicine 2025;41(13):2033-2038
Objective To explore the expression of serine/threonine protein kinase 1(AKT1)and Isocho-rismatase Domain-Containing 1(ISOC1)in gastric cancer tissues and evaluate their diagnostic utility.Methods A total of 90 patients with gastric cancer who were diagnosed and treated in our hospital between March 2023 and September 2024 were recruited as the study subjects.The positive expression rates and positive scores of AKT1 and ISOC1 in cancer tissues and adjacent tissues were compared.The AKT1 and ISOC1 positive scores of gastric cancer patients with diverse characteristics were also compared.The Spearman correlation analysis was employed to exam-ine the relationship between the expression of AKT1 and ISOC1 in cancer tissues and the clinical features of gastric cancer patients.A diagnostic model for gastric cancer,integrating AKT1 and ISOC1,was established using the Logistic regression model.Receiver operating characteristic(ROC)curves were plotted to analyze the area under the curve(AUC)value,sensitivity,and specificity of AKT1,ISOC1,and their combined diagnosis for gastric cancer.Results The positive expression rates and positive scores of AKT1 and ISOC1 in cancer tissues were significantly higher than those in paracancerous tissues(P<0.05).In gastric cancer patients,the expressions of AKT1 and ISOC1 were notably higher in patients with low differentiation,clinical stage Ⅰ~Ⅱ,invasion depth T1-2,absence of lymph node metastasis,and no distant metastasis compared to those with moderate differentiation,clinical stage Ⅲ~Ⅳ,invasion depth T3-4,and presence of lymph node metastasis and distant metastasis(P<0.05).Spearman's correlation analysis indicated that AKT1 and ISOC1 were positively correlated with the degree of differ-entiation,clinical stage,lymph node metastasis,invasion degree,and distant metastasis(P<0.05).The area under the curve(AUC)values of AKT1,ISOC1,and their combined diagnosis for gastric cancer were 0.735,0.726,and 0.875 respectively(P<0.05).The sensitivities were 60.00%,56.70%,and 75.60%,while the speci-ficities were 85.60%,83.30%,and 87.80%.The AUC value of the combined detection of AKT1 and ISOC1 in the diagnosis of gastric cancer was higher than that of AKT1 or ISOC1 alone(Z=-3.003,-3.196,P<0.05).Conclusions AKT1 and ISOC1 are highly expressed in gastric cancer tissues,and their expressions are upregu-lated with the progression of the disease.The combined detection of their expression levels holds great significance for the diagnosis and prognosis assessment of gastric cancer.
6.Serum lipidomic profiling in patients with dermatomyositis based on ultra-performance liquid chromatography-mass spectrometry
Tongchuan MA ; Xinying CAI ; Rui WANG ; Liping DONG ; Lele CHEN ; Fengli XIAO
Chinese Journal of Dermatology 2025;58(8):736-743
Objective:To investigate differences in serum lipid profiles between patients with dermatomyositis (DM) and healthy controls.Methods:A retrospective analysis was conducted on the clinical data and serum samples collected from 51 patients with DM who visited the First Affiliated Hospital, Anhui Medical University from September 2020 to January 2022. Serum samples were also collected from 66 healthy controls during the same period. Serum lipid profiles were analyzed using ultra-performance liquid chromatography-mass spectrometry in both groups. Differential lipids were screened using principal component analysis and orthogonal partial least squares-discriminant analysis. The predictive value of these differential lipids for DM was evaluated by receiver operating characteristic (ROC) curve analysis, and their correlations with clinical indicators were also evaluated.Results:A total of 51 patients with DM were enrolled, including 27 males and 24 females, with ages ( M[ Q1, Q3]) of 55.00 (47.00, 66.00) years and body mass index (BMI) values of 22.64 (19.79, 24.75) . The control group included 66 healthy individuals (33 males and 33 females) , with ages of 51.00 (43.75, 56.00) years and BMI values of 23.60 (21.18, 25.19) . No significant differences were observed between the two groups in terms of sex, age, or BMI (all P > 0.05) . A total of 341 lipid metabolites were identified, and 16 lipid metabolites such as ceramides (Cer) , sphingomyelins, phosphatidylcholines (PC) , phosphatidylethanolamines, lysophosphatidylcholines (LPC) , and triglycerides (TG) significantly differed between the DM group and the control group, of which 8 were upregulated and 8 were downregulated in the DM group. ROC curve analysis identified 7 differential lipids with area under the curve (AUC) values of > 0.9, of which 2 were Cer, 3 were TG, 1 was phosphatidylethanolamine, and 1 was LPC. In the DM patients, serum LPC (22∶1) levels were negatively correlated with creatine kinase isoenzyme MB levels ( r = -0.276, P < 0.05) , serum PC (15∶1/16∶0) levels were negatively correlated with aspartate aminotransferase levels ( r = -0.305, P < 0.05) , and serum Cer (d18∶1/18∶0) levels were positively correlated with C-reactive protein levels ( r = 0.283, P < 0.05) . Significant differences in serum lipid levels were observed between some DM subgroups (all P < 0.05) : sphingomyelin (d24∶0) levels significantly differed between anti-Sj?gren syndrome type A/Ro52 antibody-positive and -negative DM patients; LPC (17∶1) levels significantly differed between anti-PM-SCL75 antibody-positive and -negative DM patients; LPC (20∶0) and PC (32∶1p) levels significantly differed between anti-Mi-2 antibody-positive and -negative DM patients; LPC (22∶1) and TG (9∶0/9∶0/9∶0) levels significantly differed between anti-TIF1-γ antibody-positive and -negative DM patients; Cer (d18∶1/18∶0) levels significantly differed between DM patients with and without Heliotrope's sign. Conclusion:Lipid profiles were significantly altered in DM patients compared with healthy controls, and some lipids showed potential diagnostic value for DM.
7.Study on the Mechanism of miR-381 Ameliorates Ischemic Stroke by Modulating the NF-κB Signaling Pathway
Youtao ZHANG ; Liping DONG ; Shutie LI
Journal of Medical Research 2025;54(8):94-100
Objective To explore the role and mechanism of miR-381 in the pathogenesis of ischemic stroke(IS).Methods A total of 90 patients with IS treated in the First Affiliated Hospital of Hebei North University between January 2020 and December 2022 were selected as the IS group,while 110healthy volunteers were selected as the control group.Real-time fluorescence quantitative polymerase chain reaction(RT-qPCR)was used to detect the difference of serum miR-381 between the two groups,and enzyme-linked immu-nosorbent assay(ELISA)was used to measure the differences of inflammatory markers interleukin-1β(IL-1β),interleukin-6(IL-6),and tumor necrosis factor-α(TNF-α)between the groups.The CCK-8 assay was used to evaluate the effect of miR-381 on the ac-tivity of human umbilical vein endothelial cell(HUVEC).Use TargetScan,Western blot and luciferase reporter assays to validate whether inhibitor of kappa B kinase(IKK)was a target gene regulated by miR-381.An in vitro model of oxygen-glucose deprivation(OGD)was constructed,and the effects of miR-381 over-expression or inhibition on apoptosis-and inflammation-related proteins were de-tected by RT-qPCR and Western blot.The diagnostic value of miR-381 for IS was evaluated using receiver operating characteristic curve(ROC).Results Compared with the control group,the serum miR-381 levels in the IS group were significantly down-regulated(P<0.05).In comparison to the mild IS group or small infarct volume group,serum miR-381 levels were significantly lower in patients with moderate to severe IS or large infarct volumes(P were<0.05,<0.01).Additionally,compared with the control group,the serum levels of IL-1 β,IL-6 and TNF-α in the IS group were significantly higher(P were<0.01,<0.05,<0.01).Furthermore,com-pared to the mild IS group or small infarct volume group,the serum levels of IL-1 β,IL-6,and TNF-α were significantly elevated in patients with moderate to severe IS group or large infarct volume group(P were<0.01,<0.05).CCK-8 results indicated that miR-381 promoted the viability of HUVEC.Dual-Luciferase reporter gene assay results demonstrated that IKK was a direct target of miR-381.Western blot results showed that over-expression of miR-381 inhibited the activation of p65 and inhibitor of NF-κB(IKB)pro-teins,promoted the expression of the anti-apoptotic protein B-cell lymphoma 2(Bcl-2),and suppressed the expression of the pro-apoptotic protein Bcl-2 associated X(BAX).RT-qPCR results showed that over-expression miR-381 reduced the levels of NF-κB mRNA and BAX mRNA,and increased the levels of Bcl-2mRNA.ELISA results indicated that over-expression miR-381 decreased the serum levels of TNF-α,IL-6 and IL-1 β(P were<0.05,<0.01,<0.01).ROC curve analysis showed that the sensitivity and specificity of miR-381 for diagnosing IS were 76.23%and 81.25%,respectively.Conclusion miR-381 can inhibit HUVEC apopto-sis and inflammatory responses by targeting IKK,indicating its potential as a therapeutic target for IS.
8.Comparison and application of grading and classification methods for nuclear medicine workplaces
Yong YANG ; Xiang GAO ; Zhihao JU ; Haiyang DONG ; Fan BAI ; Liping ZENG
Chinese Journal of Radiological Health 2025;34(6):800-804
Objective To analyze the differences and connections between the current grading and classification methods for nuclear medicine workplaces, and to provide technical guidance for environmental impact assessments and technical reviews. Methods By comparing the objects, purposes, and computational approaches between the two methods, this article illustrates the usage of both methods through specific examples and analyzes the relationship between them. Results The two methods differed in objects, purposes, and computational approaches. The A, B, and C grading scheme was primarily used to establish the level of administrative supervision for an entire nuclear medicine workplace. In contrast, the I, II, and III classification system specifies the hardware facilities and engineering protection requirements of internal places or rooms. Conclusion These two methods are complementary and collectively provide a complete framework for the assessment of nuclear medicine workplaces.
9.Diagnostic value of plasma IL-2, IL-6 and IFN-γ in non-Hodgkin lymphoma
Qiong WU ; Liping KONG ; Yuan DONG ; Li LI ; Siyu ZONG ; Jinge XU ; Qingyun WU
Journal of Leukemia & Lymphoma 2025;34(2):80-84
Objective:To investigate the diagnostic value of plasma cytokines such as interleukin (IL)-2, IL-6 and interferon (IFN)-γ in non-Hodgkin lymphoma (NHL).Methods:A retrospective case-control study was conducted. A total of 48 NHL patients admitted to the Second Affiliated Hospital of Xuzhou Medical University between January 2020 and December 2022 were selected as NHL group, and another 34 healthy people who underwent physical examimation during the same period were selected as the healthy control group. The levels of IL-2, IL-4, IL-6, IL-10, IL-17, tumor necrosis factor (TNF) - α and IFN-γ in the plasma of patients at first admission and healthy subjects during physical examination were detected by using flow cytometry. The differences in general data and all cytokines levels of both groups were compared. The collinearity stepwise screening was made in 7 cytokines levels, and the screened variables were included in multivariate binary logistic regression model. Plasma cytokines with independent effects on the pathogenesis of NHL were screened. Taking local biopsy, histopathological examination or immunohistochemical examination as the gold standard, the receiver operating characteristic (ROC) curves of individual and combined diagnosis of NHL based on the selected cytokines were drawn to judge the diagnostic effect of all indicators on NHL.Results:There were 32 males (66.7%) and 16 females (33.3%) in NHL group, with the median age [ M ( Q1, Q3)] of 56.50 (45.75, 67.50) years; there were 28 males (82.4%) and 6 females (17.6%) in the healthy control group, with the median age of 52.00 (47.50, 55.50) years. There were no statistically significant differences in age and gender composition between the 2 groups (all P > 0.05). The levels of IL-2 [1.44 (1.36, 1.85) pg/ml vs. 1.19 (0.86, 1.68) pg/ml] and TNF-α [3.46 (2.68, 4.06) pg/ml vs. 2.23 (1.52, 3.46) pg/ml] in NHL group were higher than those in the healthy control group, and the differences were statistically significant (all P < 0.05). There were no statistically significant differences in IL-4, IL-6, IL-10, IL-17, IFN-γ levels (all P > 0.05). According to collinear stepwise screening of independent variables, IL-4 and TNF-α were excluded from 7 cytokines, and the other 5 cytokines were included in multivariate logistic regression model, and the result showed that the decreased level of IL-2 ( OR = 0.20, 95% CI: 0.08-0.53, P = 0.001) and the increased levels of IL-6 ( OR = 1.18, 95% CI: 1.04-1.33, P = 0.009) and IFN-γ ( OR = 1.26, 95% CI: 1.08-1.46, P = 0.003) were independent risk factors for the onset of NHL. The results showed that the area under the curve of IL-2, IL-6, IFN-γ and the combination of 3 indexes for the diagnosis of NHL was 0.760 (95% CI: 0.651-0.870), 0.595 (95% CI: 0.468-0.722), 0.508 (95% CI: 0.373-0.642), 0.847 (95% CI: 0.763-0.930), and the optimal cut-off value of the combination of 3 indexes was 0.730 which was calculated by logistic regression model formula; the corresponding sensitivity and specificity were 70.2% and 94.1%, respectively. Conclusions:The decreased level of IL-2 and increased levels of IL-6 and IFN-γ at initial diagnosis are risk factors for the onset of NHL. The combined detection of the 3 indexes shows a good value in the diagnosis of NHL.
10.Benvitimod attenuates atopic dermatitis by regulating the NRF2/ROS/NLRP3 signaling pathway
Yun Lu ; Liping Dong ; Maoxin Huang ; Yu Wang ; Tingyue Deng ; Fengli Xiao
Acta Universitatis Medicinalis Anhui 2025;60(8):1490-1497,1505
Objective :
To investigate the mechanism of action of benvitimod (BVM) in the treatment of atopic der- matitis (AD) .
Methods :
HaCaT cells were stimulated by TNF-α and IFN-γ , and the cells were grouped into NC group , TNF-α/IFN-γ group , TNF-α/IFN-γ BVM group , and TNF-α/IFN-γ BVM ML385 group. The AD model of DNCB-induced Balb/c mice was divided into CON group , DNCB group , DNCB + BVM group , and DNCB + TAC group. The efficacy of BVM and its roles in antioxidant and pyroptosis regulation were evaluated.
Results:
Compared with the control group , BVM inhibited the inflammatory response of HaCaT cells stimulated by TNF-α and IFN-γ , and ameliorated the skin lesions and inflammation in the DNCB-induced AD mouse model ; at the same time , it significantly increased the expression of nuclearfactorerythroid-2-relatedfactor2 (NRF2)-related anti-oxida- tive stress proteins , and significantly reduced the expression of cellular reactive oxygen species (ROS) levels and pyroptosis proteins. At the same time , the levels of NRF2-related antioxidative stress proteins significantly in- creased , and the levels of ROS and pyroptosis proteins significantly decreased.
Conclusion
BVM activates the NRF2/ROS/NLRP3 pathway to inhibit pyroptosis , thereby reducing the inflammatory response in AD.


Result Analysis
Print
Save
E-mail